vimarsana.com
Home
Live Updates
Mural Oncology Reports Inducement Grants Under Nasdaq Listin
Mural Oncology Reports Inducement Grants Under Nasdaq Listin
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass and DUBLIN, May 03, 2024 -- Mural Oncology plc , a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop...
Related Keywords
Dublin ,
Ireland ,
Katie Sullivan ,
David Borah ,
Linkedin ,
Nasdaq ,
Stock Option ,
Incentive Plan ,
Nasdaq Listing Rule ,
Mural Oncology ,